
Hagens Berman has also opened an inquiry after a short seller report alleged channel stuffing and improper revenue recognition, extending legal scrutiny following the stock’s sharp June 16 decline.
Legal scrutiny of Gildan Activewear Inc. has widened after Hagens Berman opened an investigation into whether allegations by Jehoshaphat Research are accurate and, if so, whether the company violated federal securities laws. The move follows an earlier Rosen Law Firm probe launched after a June 16, 2026 short seller report questioned Gildan’s organic growth and sales practices. In a new release, Hagens Berman said Jehoshaphat’s forensic report accused Gildan of improper channel stuffing and revenue recognition, citing interviews with former employees, customers or distributors who allegedly described efforts to pull forward sales at quarter-end through incentives, extreme payment terms and product shipments not requiring payment until after resale. Hagens Berman said Gildan shares fell more than 18% on June 16, wiping out about $2.15 billion in market value. Rosen had previously cited an 18.7% one-day drop in the NYSE-listed shares. Hagens Berman is seeking information from investors who bought Gildan on the NYSE and from potential whistleblowers with knowledge of the company’s sales practices.